Operating Segment Information (Tables)

3 Months Ended

Dec. 31, 2014

Segment Reporting [Abstract]

Segment Revenue, Operating Income and Depreciation and Amortization

The tables below present segment revenue, operating income from continuing operations and depreciation and amortization, as follows:

	Three months ended December 31
(Dollars in thousands)	2014			2013
Revenue:
Medical Device	$	10,635		$	10,549
In Vitro Diagnostics		3,570			3,334
Total revenue	$	14,205		$	13,883
Operating income:
Medical Device	$	5,515		$	5,328
In Vitro Diagnostics		1,098			671
Total segment operating income		6,613			5,999
Corporate		(1,579	)		(1,670	)
Total operating income	$	5,034		$	4,329
Depreciation and amortization:
Medical Device	$	270		$	294
In Vitro Diagnostics		213			214
Corporate		200			189
Total depreciation and amortization	$	683		$	697